NCT01380236View on ClinicalTrials.gov

A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

May 31, 2013

Conditions
Asthma
Interventions
DRUG

ASM8

Sponsors

Lead Sponsor

Syntara
All Listed Sponsors
lead

Syntara

INDUSTRY

NCT01380236 - A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma | Biotech Hunter | Biotech Hunter